NOVAVAX INC

Ticker: NVAX CUSIP: 670002401 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 929,611 Value ($000) $6,247 Avg Close $7.54 Range $6.20 - $9.75
Q3 2025
Shares 50,595 Value ($000) $439 Avg Close $7.78 Range $6.23 - $10.64
Q3 2024
Shares 148,917 Value ($000) $1,881 Avg Close $12.91 Range $8.87 - $17.81
Q2 2024
Shares 362,690 Value ($000) $4,592 Avg Close $10.06 Range $3.81 - $23.86
Q2 2022
Shares 160,157 Value ($000) $8,235 Avg Close $51.73 Range $34.88 - $77.65
Q1 2022
Shares 16,554 Value ($000) $1,219 Avg Close $89.17 Range $65.82 - $145.20
Q4 2021
Shares 45,591 Value ($000) $6,522 Avg Close $171.82 Range $121.35 - $236.50
Q3 2021
Shares 15,860 Value ($000) $3,288 Avg Close $220.39 Range $172.01 - $277.80
Q2 2021
Shares 40,905 Value ($000) $8,684 Avg Close $183.22 Range $117.12 - $263.67
Q1 2021
Shares 50,758 Value ($000) $9,202 Avg Close $199.27 Range $109.01 - $331.68
Q4 2020
Shares 2,877 Value ($000) $321 Avg Close $106.29 Range $76.59 - $150.50